SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Maxim Group Upgrades Adamis Pharmaceuticals to Buy, Announces $1.5 Price Target

Maxim Group analyst Jason McCarthy upgrades Adamis Pharmaceuticals (NASDAQ:ADMP) from Hold to Buy and announces $1.5 price target.

Benzinga · 05/13/2020 15:34

Maxim Group analyst Jason McCarthy upgrades Adamis Pharmaceuticals (NASDAQ:ADMP) from Hold to Buy and announces $1.5 price target.